957205-14-0

Basic information

• Product Name: 3,6,9,12-Tetraoxatetradecan-1-ol, 14-bromo-
• Synonyms: 3,6,9,12-Tetraoxatetradecan-1-ol, 14-bromo-;14-bromo-3,6,9,12-tetraoxatetradecan-1-ol;Bromo-PEG5-alcohol;Br-PEG5-OH
• CAS NO: 957205-14-0
• Molecular Formula: C10H21BrO5
• Molecular Weight: 301
• Mol File: 957205-14-0.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• Solubility: Soluble in DCM
• CAS DataBase Reference: 3,6,9,12-Tetraoxatetradecan-1-ol, 14-bromo-(CAS DataBase Reference)
• NIST Chemistry Reference: 3,6,9,12-Tetraoxatetradecan-1-ol, 14-bromo-(957205-14-0)
• EPA Substance Registry System: 3,6,9,12-Tetraoxatetradecan-1-ol, 14-bromo-(957205-14-0)

Safety Data

• Hazardous Substances Data: 957205-14-0(Hazardous Substances Data)

Usage

Description

Bromo-PEG5-alcohol is a PEG linker containing a bromide group and a terminal hydroxyl group. The hydrophilic PEG spacer increases solubility in aqueous media. The bromide (Br) is a very good leaving group for nucleophilic substitution reactions. The hydroxyl group enables further derivatization or replacement with other reactive functional groups.

Upstream product

• 155130-15-7 2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethyl 4-methylbenzenesulfonate 

Relevant articles and documents

BIHETEROCYCLIC COMPOUND

The present invention provides a compound of formula (1) and a pharmaceutical composition comprising the compound useful as a nerve regeneration promoter wherein R1-L- is R1—OC(O)—, or the like, R1 is hydrogen atom, optionally-substituted C1-6 alkyl group, optionally-substituted 3- to 8-membered cycloalkyl group, or the like, R2 is hydrogen atom or the like, Ring A is formula (2) or formula (3) wherein R3 is hydrogen atom, optionally-substituted C1-6 alkyl group, or the like, the part of X, Y, and Z is X═Y—Z, X—Y═Z, or X—Y—Z, X is nitrogen atom, NR4 (R4 is hydrogen atom, optionally-substituted C1-6 alkyl group, or the like), or the like, Y is carbon atom or the like, and Z is carbon atom, nitrogen atom or the like.